Literature DB >> 32020962

Metabolic syndrome: The Indian public health perspective.

Rajvir Bhalwar1.   

Abstract

Metabolic Syndrome (MetS) is a clustering of specific risk factors, namely, central obesity, raised blood pressure, impaired fasting glucose, raised triglycerides, and low levels of high-density lipoprotein-cholesterol (HDL-C). This constellation is triggered by insulin resistance and its resultant hyperinsulinemia. The two most important and universally agreed causes of insulin resistance are increased body fat (particularly central obesity) and physical inactivity. Other causes include certain genetic/pro-genetic factors, unhealthy atherogenic diet, tobacco use, and excessive alcohol intake. Within 3 decades of the initial description of MetS by Reaven, various defining criteria have been developed by now, by leading international professional bodies, the most commonly used being the one given by the Adult Treatment Panel III (ATP III) report of the National Cholesterol Education Program (NCEP) [NCEP-ATP-III], the updated guidelines recently released by the American College of Cardiology (ACC) and the American Heart Association (AHA). MetS has been well documented to increase the risk of ischemic heart disease (IHD) by two to three times and of type 2 diabetes mellitus (T2DM) by five times. The world-wide prevalence is on the increase, with the overall global prevalence estimated to be 20%-25% of the adult population. In our country, various epidemiological studies undertaken across the country have consistently shown a high prevalence, which is likely to be as much as one-quarter of the adult population, with increasing age and female gender being at higher risk. The occurrence has also been recorded among the Armed Forces personnel as well as in adolescents. MetS has therefore become a priority issue for both, the public health providers as well as for the clinicians in our country, and needs concerted, all-round efforts for its prevention, early detection, management, and research. Against this background, the various public health measures for prevention and control of MetS have been suggested in this review.
© 2020 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.

Entities:  

Keywords:  Community health; Insulin resistance; Metabolic syndrome; Non-communicable diseases; Prevention

Year:  2020        PMID: 32020962      PMCID: PMC6994803          DOI: 10.1016/j.mjafi.2019.12.001

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  26 in total

1.  Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)

Authors:  B Balkau; M A Charles
Journal:  Diabet Med       Date:  1999-05       Impact factor: 4.359

Review 2.  Prevalence of metabolic syndrome in Pakistan.

Authors:  Abdul Basit; A Samad Shera
Journal:  Metab Syndr Relat Disord       Date:  2008-09       Impact factor: 1.894

Review 3.  Management issues in the metabolic syndrome.

Authors:  P C Deedwania; R Gupta
Journal:  J Assoc Physicians India       Date:  2006-10

4.  Metabolic syndrome among rural Indian adults.

Authors:  Anamitra Barik; Kausik Das; Abhijit Chowdhury; Rajesh Kumar Rai
Journal:  Clin Nutr ESPEN       Date:  2017-12-01

5.  Cardiovascular diseases in India.

Authors:  K S Reddy
Journal:  World Health Stat Q       Date:  1993

6.  Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians.

Authors:  P M McKeigue; B Shah; M G Marmot
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

7.  Prevalence of metabolic syndrome crossing 40% in Northern India: Time to act fast before it runs out of proportions.

Authors:  Yasmee Khan; Arati Lalchandani; Ajesh Chandra Gupta; Sagar Khadanga; Sanjeev Kumar
Journal:  J Family Med Prim Care       Date:  2018 Jan-Feb

8.  Prevalence and Determinants of Metabolic Syndrome among the Rural Adult Population of Puducherry.

Authors:  Vinayagamoorthy Venugopal; Amol R Dongre; Sumathi Saravanan
Journal:  Indian J Community Med       Date:  2019 Jan-Mar

Review 9.  A clinical perspective of obesity, metabolic syndrome and cardiovascular disease.

Authors:  Thang S Han; Mike Ej Lean
Journal:  JRSM Cardiovasc Dis       Date:  2016-02-25

10.  Prevalence of metabolic syndrome and its risk factors in Kerala, South India: Analysis of a community based cross-sectional study.

Authors:  S Harikrishnan; Smitha Sarma; G Sanjay; P Jeemon; M N Krishnan; K Venugopal; P P Mohanan; L Jeyaseelan; K R Thankappan; G Zachariah
Journal:  PLoS One       Date:  2018-03-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.